source:[1] Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly - cnbc.com (https://www.cnbc.com/2025/12/11/zealand-pharm ...)[2] Zealand pens $2.5B oral cardiometabolic collab with fresh-faced Chinese biotech - Fierce Biotech (https://www.fiercebiotech.com/biotech/zealand ...)[3] Zealand Bets Up To $2.5B in Metabolic Pact With Chinese Biotech - BioSpace (https://www.biospace.com/business/zealand-bet ...)